Chloroquine or hydroxychloroquine for prophylaxis of COVID-19

Share this page:

Title

Subject

Description

In-vitro studies have shown that chloroquine is effective against several viruses, including severe acute respiratory syndrome coronavirus (SARS-CoV).

Creator

Principi, Nicola, and Susanna Esposito.

Date Last Updated (Year-Month-Day)

2020-04-17

Type

Publication

Citation

Principi, Nicola, and Susanna Esposito. 2020. "Chloroquine or hydroxychloroquine for prophylaxis of COVID-19." The Lancet Infectious Diseases.

Accessibility

Free online on Lancet site.

URL

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30296-6/fulltext

Read Online

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30296-6/fulltext

Click for External Resource*

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30296-6/fulltext

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Item Type:

Publication

Collection

Discover

Citation for this page

Principi, Nicola, and Susanna Esposito. , “Chloroquine or hydroxychloroquine for prophylaxis of COVID-19,” NETEC Resource Library, accessed October 26, 2021, https://repository.netecweb.org/items/show/973.

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.